Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABRAXAS1 pseudogene 1 (ABRAXAS1P1) is a pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional ABRAXAS1 gene, which encodes a protein involved in DNA damage repair as part of the BRCA1-A complex[7]. Pseudogenes do not produce a functional protein and have no known direct biological function or disease association[7]. Therefore, ABRAXAS1P1 is not considered a therapeutic target and lacks known roles in human disease, biological function, druggability, or clinical application. Additional clarification: - If you are seeking information on the functional protein-coding gene ABRAXAS1 (also known as FAM175A, CCDC98), that gene is involved in DNA repair and cancer susceptibility[1][2][3], but ABRAXAS1P1 itself is not a functional target. - The designation “pseudogene” strongly implies there is no biological or therapeutic relevance to patient targeting, biomarker work, or drug interaction[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ABRAXAS1 pseudogene 1 (ABRAXAS1P1).